1. Home
  2. RMNI vs AURA Comparison

RMNI vs AURA Comparison

Compare RMNI & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMNI
  • AURA
  • Stock Information
  • Founded
  • RMNI 2005
  • AURA 2007
  • Country
  • RMNI United States
  • AURA United States
  • Employees
  • RMNI N/A
  • AURA N/A
  • Industry
  • RMNI Business Services
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMNI Consumer Discretionary
  • AURA Health Care
  • Exchange
  • RMNI Nasdaq
  • AURA Nasdaq
  • Market Cap
  • RMNI 368.8M
  • AURA 370.1M
  • IPO Year
  • RMNI N/A
  • AURA 2021
  • Fundamental
  • Price
  • RMNI $3.57
  • AURA $5.26
  • Analyst Decision
  • RMNI Buy
  • AURA Strong Buy
  • Analyst Count
  • RMNI 2
  • AURA 4
  • Target Price
  • RMNI $6.00
  • AURA $22.75
  • AVG Volume (30 Days)
  • RMNI 230.8K
  • AURA 180.9K
  • Earning Date
  • RMNI 05-01-2025
  • AURA 05-20-2025
  • Dividend Yield
  • RMNI N/A
  • AURA N/A
  • EPS Growth
  • RMNI N/A
  • AURA N/A
  • EPS
  • RMNI N/A
  • AURA N/A
  • Revenue
  • RMNI $426,212,000.00
  • AURA N/A
  • Revenue This Year
  • RMNI $0.74
  • AURA N/A
  • Revenue Next Year
  • RMNI $4.46
  • AURA N/A
  • P/E Ratio
  • RMNI N/A
  • AURA N/A
  • Revenue Growth
  • RMNI N/A
  • AURA N/A
  • 52 Week Low
  • RMNI $1.53
  • AURA $4.84
  • 52 Week High
  • RMNI $4.15
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • RMNI 58.47
  • AURA 43.64
  • Support Level
  • RMNI $3.22
  • AURA $4.94
  • Resistance Level
  • RMNI $3.45
  • AURA $5.92
  • Average True Range (ATR)
  • RMNI 0.21
  • AURA 0.47
  • MACD
  • RMNI 0.02
  • AURA 0.00
  • Stochastic Oscillator
  • RMNI 90.38
  • AURA 23.70

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: